NCT01721096View on ClinicalTrials.gov

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

CompletedOBSERVATIONAL
Enrollment

536

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

November 30, 2018

Conditions
AnginaCoronary OcclusionCoronary Artery DiseaseCoronary Artery StenosisMyocardial Ischemia
Interventions
DEVICE

XIENCE PRIME - Long Length (LL)

Long Length

DEVICE

XIENCE PRIME - Core Size

Core Size

Trial Locations (1)

108-6304

Abbott Vascular Japan Co., Ltd., Tokyo

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY